Corroborating these findings, TGM4 overexpression increased migration of PC-3, PZ-HPV-7, and DU145 prostate cancer cells, while TGM4 knockdown by ribozyme transgene reduced EMT of CAHPV-10 prostate cancer cells [275]. The gene discussed is TGM4; the disease is prostate carcinoma.